Advertisement
Screener

KALEIDO BIOSCIENCES, INC. Increase (Decrease) in Accrued Liabilities

KALEIDO BIOSCIENCES, INC. Increase (Decrease) in Accrued Liabilities

KALEIDO BIOSCIENCES, INC. reported Increase (Decrease) in Accrued Liabilities of -$394.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-01.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2022-04-01

  • KALEIDO BIOSCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2021-12-31 was -$1.37M.
  • KALEIDO BIOSCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2021-09-30 was $3.54M, a 211.88% increase year-over-year.
  • KALEIDO BIOSCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2021-06-30 was $394.00K, a 398.73% increase year-over-year.
  • KALEIDO BIOSCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2021-03-31 was -$2.96M, a 569.41% decline year-over-year.
  • KALEIDO BIOSCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2021 was -$394.00K, a 123.05% decline from fiscal 2020.
  • KALEIDO BIOSCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2020 was $1.71M, a 26.69% increase from fiscal 2019.
  • KALEIDO BIOSCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2019 was $1.35M, a 71.43% decline from fiscal 2018.
  • KALEIDO BIOSCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2018 was $4.72M.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 12 month
2021-12-31-$1.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01
$2.17M
derived: sum of 2 quarters · filed 2022-04-01
$2.57M
derived: sum of 3 quarters · filed 2022-04-01
-$394.00K
10-K · filed 2022-04-01
2021-09-30$3.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01
$3.94M
derived: sum of 2 quarters · filed 2021-11-01
$975.00K
10-Q · filed 2021-11-01
$838.00K
derived: sum of 4 quarters · filed 2022-04-01
2021-06-30$394.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
-$2.57M
10-Q · filed 2021-08-11
-$2.71M
derived: sum of 3 quarters · filed 2022-04-01
-$1.57M
derived: sum of 4 quarters · filed 2022-04-01
2021-03-31-$2.96M
10-Q · filed 2021-05-04
-$3.10M
derived: sum of 2 quarters · filed 2022-04-01
-$1.96M
derived: sum of 3 quarters · filed 2022-04-01
-$1.88M
derived: sum of 4 quarters · filed 2022-04-01
2020-12-31-$137.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01
$999.00K
derived: sum of 2 quarters · filed 2022-04-01
$1.08M
derived: sum of 3 quarters · filed 2022-04-01
$1.71M
10-K · filed 2022-04-01
2020-09-30$1.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01
$1.22M
derived: sum of 2 quarters · filed 2021-11-01
$1.85M
10-Q · filed 2021-11-01
$2.31M
derived: sum of 4 quarters · filed 2021-11-01
2020-06-30$79.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$710.00K
10-Q · filed 2021-08-11
$1.18M
derived: sum of 3 quarters · filed 2021-08-11
$3.31M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$631.00K
10-Q · filed 2021-05-04
$1.10M
derived: sum of 2 quarters · filed 2021-05-04
$3.23M
derived: sum of 3 quarters · filed 2021-05-04
$4.52M
derived: sum of 4 quarters · filed 2021-05-04
2019-12-31$468.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03
$2.60M
derived: sum of 2 quarters · filed 2021-03-03
$3.89M
derived: sum of 3 quarters · filed 2021-03-03
$1.35M
10-K · filed 2021-03-03
2019-09-30$2.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02
$3.42M
derived: sum of 2 quarters · filed 2020-11-02
$881.00K
10-Q · filed 2020-11-02
$3.30M
derived: sum of 4 quarters · filed 2020-11-02
2019-06-30$1.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
-$1.25M
10-Q · filed 2020-08-04
$1.17M
derived: sum of 3 quarters · filed 2020-08-04
$2.88M
derived: sum of 4 quarters · filed 2020-08-04
2019-03-31-$2.54M
10-Q · filed 2020-05-14
-$128.00K
derived: sum of 2 quarters · filed 2020-05-14
$1.58M
derived: sum of 3 quarters · filed 2020-05-14
$2.17M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$2.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$4.13M
derived: sum of 2 quarters · filed 2020-03-02
$4.71M
derived: sum of 3 quarters · filed 2020-03-02
$4.72M
10-K · filed 2020-03-02
2018-09-30$1.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
$2.29M
derived: sum of 2 quarters · filed 2019-10-30
$2.31M
10-Q · filed 2019-10-30
2018-06-30$581.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$594.00K
10-Q · filed 2019-08-01
2018-03-31$13.00K
10-Q · filed 2019-05-02